Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway

The molecular mechanism underlying the metabolic reprogramming associated with obesity and high blood cholesterol levels is poorly understood. We previously reported that cholesterol is an endogenous ligand of the estrogen-related receptor alpha (ERRα). Using functional assays, metabolomics, and gen...

Full description

Bibliographic Details
Main Authors: Faegheh Ghanbari, Anne-Marie Fortier, Morag Park, Anie Philip
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
n/a
Online Access:https://www.mdpi.com/2072-6694/13/11/2605
_version_ 1797532593805066240
author Faegheh Ghanbari
Anne-Marie Fortier
Morag Park
Anie Philip
author_facet Faegheh Ghanbari
Anne-Marie Fortier
Morag Park
Anie Philip
author_sort Faegheh Ghanbari
collection DOAJ
description The molecular mechanism underlying the metabolic reprogramming associated with obesity and high blood cholesterol levels is poorly understood. We previously reported that cholesterol is an endogenous ligand of the estrogen-related receptor alpha (ERRα). Using functional assays, metabolomics, and genomics, here we show that exogenous cholesterol alters the metabolic pathways in estrogen receptor-positive (ER+) and triple-negative breast cancer (TNBC) cells, and that this involves increased oxidative phosphorylation (OXPHOS) and TCA cycle intermediate levels. In addition, cholesterol augments aerobic glycolysis in TNBC cells although it remains unaltered in ER+ cells. Interestingly, cholesterol does not alter the metabolite levels of glutaminolysis, one-carbon metabolism, or the pentose phosphate pathway, but increases the NADPH levels and cellular proliferation, in both cell types. Importantly, we show that the above cholesterol-induced modulations of the metabolic pathways in breast cancer cells are mediated via ERRα. Furthermore, analysis of the ERRα metabolic gene signature of basal-like breast tumours of overweight/obese versus lean patients, using the GEO database, shows that obesity may modulate ERRα gene signature in a manner consistent with our in vitro findings with exogenous cholesterol. Given the close link between high cholesterol levels and obesity, our findings provide a mechanistic explanation for the association between cholesterol/obesity and metabolic reprogramming in breast cancer patients.
first_indexed 2024-03-10T11:02:26Z
format Article
id doaj.art-6a0c0236b22e4cf9a0f655dd9b6c079c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T11:02:26Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-6a0c0236b22e4cf9a0f655dd9b6c079c2023-11-21T21:25:58ZengMDPI AGCancers2072-66942021-05-011311260510.3390/cancers13112605Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα PathwayFaegheh Ghanbari0Anne-Marie Fortier1Morag Park2Anie Philip3Division of Plastic Surgery, Department of Surgery, Faculty of Medicine, McGill University, Montreal, QC H3G 1A4, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, CanadaGoodman Cancer Research Centre, McGill University, Montreal, QC H3A 1A3, CanadaDivision of Plastic Surgery, Department of Surgery, Faculty of Medicine, McGill University, Montreal, QC H3G 1A4, CanadaThe molecular mechanism underlying the metabolic reprogramming associated with obesity and high blood cholesterol levels is poorly understood. We previously reported that cholesterol is an endogenous ligand of the estrogen-related receptor alpha (ERRα). Using functional assays, metabolomics, and genomics, here we show that exogenous cholesterol alters the metabolic pathways in estrogen receptor-positive (ER+) and triple-negative breast cancer (TNBC) cells, and that this involves increased oxidative phosphorylation (OXPHOS) and TCA cycle intermediate levels. In addition, cholesterol augments aerobic glycolysis in TNBC cells although it remains unaltered in ER+ cells. Interestingly, cholesterol does not alter the metabolite levels of glutaminolysis, one-carbon metabolism, or the pentose phosphate pathway, but increases the NADPH levels and cellular proliferation, in both cell types. Importantly, we show that the above cholesterol-induced modulations of the metabolic pathways in breast cancer cells are mediated via ERRα. Furthermore, analysis of the ERRα metabolic gene signature of basal-like breast tumours of overweight/obese versus lean patients, using the GEO database, shows that obesity may modulate ERRα gene signature in a manner consistent with our in vitro findings with exogenous cholesterol. Given the close link between high cholesterol levels and obesity, our findings provide a mechanistic explanation for the association between cholesterol/obesity and metabolic reprogramming in breast cancer patients.https://www.mdpi.com/2072-6694/13/11/2605n/a
spellingShingle Faegheh Ghanbari
Anne-Marie Fortier
Morag Park
Anie Philip
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
Cancers
n/a
title Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
title_full Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
title_fullStr Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
title_full_unstemmed Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
title_short Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
title_sort cholesterol induced metabolic reprogramming in breast cancer cells is mediated via the errα pathway
topic n/a
url https://www.mdpi.com/2072-6694/13/11/2605
work_keys_str_mv AT faeghehghanbari cholesterolinducedmetabolicreprogramminginbreastcancercellsismediatedviatheerrapathway
AT annemariefortier cholesterolinducedmetabolicreprogramminginbreastcancercellsismediatedviatheerrapathway
AT moragpark cholesterolinducedmetabolicreprogramminginbreastcancercellsismediatedviatheerrapathway
AT aniephilip cholesterolinducedmetabolicreprogramminginbreastcancercellsismediatedviatheerrapathway